Welc0me

Groundbreaking discoveries in the field of psychopharmacology within the past few decades have revolutionized our conception of personality and its mutability, as well as blurred the distinction between the therapeutic treatment of pathology and the pharmacological augmentation of self. Antidepressants such as monoamine oxidase inhibitors (MAOIs) or Prozac have been documented to make some patients feel "better than well" in a fashion that is both sustainable and productive. The personalities of some patients on these drugs undergo an extreme and positive metamorphosis that years of psychotherapy could not induce. Another class of drugs called "nootropics," colloquially known as "smart drugs," have reportedly increased various cognitive abilities in clinical trials as inferred from accepted and standardized psychological tests. Not only have various classes of drugs been documented to sustainably increase facets of cognition and mood in pathological patients, but data indicate that this efficacy may carry over to people that are free of pathology. That is, through pharmacology the productivity, mood, and cognitive abilities of healthy subjects of any age could potentially be augmented.